Abstract：Objective To explore the effect of Metformin on reducing the incidence rate of Alzheimer′s disease(AD)in the patients with type 2 diabetes mellitus.Methods A total of 90 patients with type 2 diabetes mellitus who were admitted to our hospital from January to December in 2017,were selected as the research subjects,and were randomly divided into observation group and control group according to the random number table,45 patients in each group.The observation group were given Metformin,and patients in the control group were given Acarbose Tablets for treatment.The effect of different treatment methods on the therapeutic effect,insulin resistance (HOMA-IR),AD,and incidence rate of adverse reactions were compared between the two groups of patients.Results The observation group was significantly lower than that in the control group in terms of fasting plasma glucose(FBG),2 h postprandial blood glucose(2 h PG),fasting insulin(FINs),glycosylated hemoglobin(HbA1c),peripheral blood leukocyte,body mass index(BMI)(P＜0.05).The blood vitamin B12and connecting peptide(C peptide)were significantly higher than that in the control group(P＜0.05).The observation group was significantly lower than that in the control group in terms of HOMA-IR(P＜0.05).The incidence rate of AD and adverse reactions was significantly lower than that in the control group,the differences were statistically significant(P＜0.05).Conclusion When Metformin is used in the patients with type 2 diabetes,it can not only reduce HOMA-IR and the incidence rate of AD，it can also improve the patient-related indicators,maintain blood sugar stability,and the incidence rate of adverse reactions is less.This method is worthy of application and promotion.
许晓玲. 二甲双胍对降低2型糖尿病患者阿尔茨海默病发病率的效果分析[J]. 中国当代医药, 2018, 25(13): 135-137.
XU Xiao-ling. Analysis on the effect of Metformin on reducing the incidence rate of Alzheimer′s disease in the patients with type 2 diabetes mellitus. 中国当代医药, 2018, 25(13): 135-137.
京公网安备 11010502046607号